SARS-CoV-2 seroprevalence and living conditions in Bamako (Mali): a cross-sectional multistage household survey after the first epidemic wave, 2020

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by IRD (French National Research Institute for Sustainable Development); the JEAI DynaSTEC (Spatio-Temporal Dynamics of Epidemics and Environmental Changes research team); the French Embassy in Mali (field data collection) and the Charles Merieux Foundation, Lyon (laboratory analyses); the NGO Prospective and Cooperation. The funders had no role in the study design, data collection plan, analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The authorization to conduct the study was obtained on August 28th, 2020, from the Ministry of Health and Social Affairs of Mali (decision letter number 2020-001424-MSAS-SG). Clearance from the ethics committee of the Faculties of Medicine and Odonto-Stomatology and Pharmacy, University of Sciences, Technics and Technologies of Bamako (Mali) was obtained on August 10th, 2020 (clearance letter number 2020/162/CA/FMOS/FAPH). First, a community agreement was first obtained from district leaders, local religious leaders, community associations and municipal authorities after explanation and discussion about the study protocol. Second, consents and/or assents of participants or their parent/guardian were obtained. The study team administered consent in local languages, and, if the participant or parent/guardian was not literate, in the presence of a witness. Individuals from each family consented separately.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes